OpenScience.ink

1 week ago • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

How Biased Signaling and Small Molecules Interact with the GLP-1 Receptor to Help Treat Type 2 Diabetes and Obesity, Based on Molecular SimulationsUnderstanding Biased Signaling and Small-Molecule Binding for Treatment of Type 2 Diabetes Mellitus and Obesity at the Glucagon-Like Peptide-1 Receptor (GLP-1R) Based on Molecular Dynamics Simulations.

📖 Top 50% JournalArticle

1 week ago • Journal of managed care & specialty pharmacy

Stopping glucagon-like peptide-1 receptor drugs among US adults: results from a national surveyDiscontinuation of glucagon-like peptide-1 receptor agonists among US adults: A national survey.

📖 Top 20% JournalArticle

1 week ago • Metabolites

Using GLP-1 Receptor Agonists as Additional Metabolic Treatment After Liver Cancer SurgeryThe Liver Left Behind: GLP-1 Receptor Agonists and the Prospect of Metabolic Adjuvant Therapy After HCC Resection.

📖 Top 20% JournalEditorial

1 week ago • Journal of cardiovascular development and disease

GLP-1 Receptor Drugs as Possible Heart Protectors During Cardiac SurgeryGLP-1 Receptor Agonists in Cardiac Surgery: From Metabolic Drug to Potential Perioperative Cardioprotective Agent.

📖 Top 30% JournalArticle

1 week ago • Diabetes & metabolic syndrome

Changes in Eating Habits During Treatment with GLP-1 Receptor AgonistsNutritional intake changes during GLP-1 receptor agonist therapy: A systematic review and meta-analysis.

📖 Top 20% JournalArticle

1 week ago • Journal of visualized experiments : JoVE

Saxagliptin with Liraglutide versus Saxagliptin Alone and Their Effects on Inflammation and Fat Hormones in Obese Type 2 Diabetes Patients Not Responding Well to MetforminSaxagliptin Combined with Liraglutide vs. Saxagliptin Alone on Microinflammation and Adipokines in Obese T2DM Patients with Poor Metformin Response.

📖 Top 50% JournalVideo-Audio Media

1 week ago • Cells

Incretin-Based Treatments, Obesity-Related Inflammation, and Risk of Artery DiseaseIncretin-Based Therapies, Obesity-Associated Inflammation, and Atherosclerotic Cardiovascular Risk.

🎖️ Top 10% JournalArticle

1 week ago • Metabolites

Body Weight and Fat Changes in Children Using GLP-1 Medicine for Obesity: A Pilot StudyBody Composition Changes During GLP-1 Receptor Agonist Therapy in Pediatric Obesity: A Pilot Study.

📖 Top 20% JournalArticle

1 week ago • Appetite

GLP-1 receptor drugs for obesity in teenagers during a key growth phaseGLP-1 receptor agonists in adolescent obesity: Incretin-based therapies during a sensitive developmental period.

📖 Top 20% JournalArticle

1 week ago • PharmacoEconomics

Cost-effectiveness of Semaglutide and Resmetirom (80 mg and 100 mg) Compared to Standard Treatment for Metabolic Liver Disease in the USA Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

🎖️ Top 10% Journal

1 week ago • Cureus

Possible Reduction of Early Weight Loss with Tirzepatide in a Patient Also Taking Levosulpiride: A Case Report and ExplanationPossible Attenuation of Early Weight Loss During Tirzepatide Therapy in a Patient Treated With Levosulpiride: A Case Report and Mechanistic Hypothesis.

1 week ago • Cureus

How Metabolism and Hormones Work Together: A New View on Reproduction and Metabolism in the GLP-1 Treatment EraMetabolic-Hormonal Interplay and the Case for a Reproductive-Metabolic Framework in the Glucagon-Like Peptide-1 (GLP-1) Era.

1 week ago • Obesity reviews : an official journal of the International Association for the Study of Obesity

How Often People with Overweight or Obesity Do Not Follow GLP-1 Receptor Agonist Treatment: A Review of Clinical TrialsNonadherence to GLP-1 Receptor Agonists Among Individuals With Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

← prevpage 5 of 14next →

Latest GLP-1 Therapies Research Papers